African health sciences · 2026
Prediabetes and diabetes among patients presenting with acute stroke or acute coronary syndrome at a tertiary regional referral centre in Kenya.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Owino Beverly, Shah Jasmit, Visram Hasina, Njenga Eric, Kunyiha Nancy
Аннотация
BACKGROUND: Diabetes and pre-diabetes are significant risk factors for acute coronary syndrome (ACS) and acute primary stroke (APS). Dysglycemia in any context is under-diagnosed or identified late in resource-poor countries such as in sub-Saharan Africa (SSA), especially when the patient is not known to have pre-morbid diabetes.
MATERIALS AND METHODS: We conducted a prospective cross-sectional study at the Aga Khan University Hospital, Nairobi. Inclusion criteria: consenting adults ≥18 years admitted with ACS/APS during the period April 2021-February 2022 inclusive. HbA1C was used to determine the glycemic status. Definition of diabetes and pre-diabetes was based on the American Diabetes Association guidelines.
RESULTS: From a total of 211 patients [144 (81.2%) of African race], the median age of the patients was 58 (49-68) years with a male to female ratio of 2.5:1. 47.4% (n = 100) had ACS and 52.6% (n=111) had APS. The prevalence of dysglycemia was 68.2% (95% CI: 61.5%-74.5%) with the prevalence of pre-diabetes being 30.3% (64/211) and type 2 diabetes 37.9% (80/211). Of the patients with dysglycemia, 47.9% (69/144) had a new diagnosis.
CONCLUSION: This study shows a remarkably high prevalence of dysglycemia in patients with ACS/APS. The new diagnosis of pre-diabetes prevalence was comparable to diabetes in these patients, adding to the evidence that prediabetes portends significant cardiometabolic consequences and effects over and above the development of type 2 diabetes.
MATERIALS AND METHODS: We conducted a prospective cross-sectional study at the Aga Khan University Hospital, Nairobi. Inclusion criteria: consenting adults ≥18 years admitted with ACS/APS during the period April 2021-February 2022 inclusive. HbA1C was used to determine the glycemic status. Definition of diabetes and pre-diabetes was based on the American Diabetes Association guidelines.
RESULTS: From a total of 211 patients [144 (81.2%) of African race], the median age of the patients was 58 (49-68) years with a male to female ratio of 2.5:1. 47.4% (n = 100) had ACS and 52.6% (n=111) had APS. The prevalence of dysglycemia was 68.2% (95% CI: 61.5%-74.5%) with the prevalence of pre-diabetes being 30.3% (64/211) and type 2 diabetes 37.9% (80/211). Of the patients with dysglycemia, 47.9% (69/144) had a new diagnosis.
CONCLUSION: This study shows a remarkably high prevalence of dysglycemia in patients with ACS/APS. The new diagnosis of pre-diabetes prevalence was comparable to diabetes in these patients, adding to the evidence that prediabetes portends significant cardiometabolic consequences and effects over and above the development of type 2 diabetes.